SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-022477
Filing Date
2010-03-09
Accepted
2010-03-09 14:20:08
Documents
13
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K g22405e10vk.htm 10-K 664171
2 EX-10.13 g22405exv10w13.htm EX-10.13 4378
3 EX-10.16 g22405exv10w16.htm EX-10.16 108954
4 EX-10.33 g22405exv10w33.htm EX-10.33 21109
5 EX-23 g22405exv23.htm EX-23 4982
6 EX-31.1 g22405exv31w1.htm EX-31.1 8250
7 EX-31.2 g22405exv31w2.htm EX-31.2 8505
8 EX-32.1 g22405exv32w1.htm EX-32.1 3349
9 EX-32.2 g22405exv32w2.htm EX-32.2 3067
10 GRAPHIC g22405g2240500.gif GRAPHIC 13324
11 GRAPHIC g22405g2240501.gif GRAPHIC 148806
12 GRAPHIC g22405g2240502.gif GRAPHIC 173974
13 GRAPHIC g22405g2240503.gif GRAPHIC 133282
  Complete submission text file 0000950123-10-022477.txt   1475500
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 10666487
SIC: 2836 Biological Products, (No Diagnostic Substances)